Built for investment bankers and valuation experts, ExelenceAI automates LBO, M&A, and DCF models, bringing generative AI precision to the core of ...
How to accelerate your team's quality and output without expensive training programs or time-consuming performance plans.
In the news release, GenerativeX Introduces "ExcelenceAI" - The AI Agent for Deal-Ready Financial Modeling in Excel, issued on November 4, 2025 by ...
Privia Health Group, Inc. offers high-growth potential with recurring revenue model and strong relationships. Learn more ...
Kinsale Capital’s strong growth, solid fundamentals, and attractive valuation present unique investment opportunities. Read here for more on KNSL stock.
U.S. in Progress, organized by Poland’s Tauron American Film Festival, has announced its winners. In total, 20 awards with a ...
If you’ve been eyeing Owens Corning stock and trying to decide whether it’s a smart play right now, you’re not alone. The company’s share price has certainly kept investors on their toes in recent ...
The Register on MSN
Anthropic's Claude is learning Excel so you don't have to
Good luck to the 1,000 enterprise guinea pigs on the initial preview Anthropic has opened a waitlist for Claude for Excel, promising spreadsheet devotees that its LLM will be able to understand their ...
Anthropic, the AI startup backed by Amazon and Google, has expanded Claude for Financial Services with an Excel ad-in and more connectors to real-time market data and portfolio analytics, including ...
Mind Medicine (MindMed) revealed that its lead candidate, MM120, achieved strong results in Phase 2b studies targeting generalized anxiety disorder. The company secured FDA Breakthrough Therapy status ...
If you are eyeing Cooper Companies and wondering whether now is the time to jump in or sit tight, you are definitely not alone. The stock has taken investors on quite a ride recently, with gains of ...
Summit Therapeutics (SMMT) has caught investors' attention following its latest stock movement, with shares changing hands at $20.99 after a recent monthly climb of 16%. This uptick stands out amid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results